Although studies often associate miR-132 downregulation with reduced inflammation, in PCOS patients, its upregulation might aid in modulating insulin sensitivity and inflammation, complementing metformin’s metabolic and anti-inflammatory effects [49]. The gene discussed is INS; the disease is polycystic ovary syndrome.